Oestrogens and psychological well-being

Annals of Medicine

Volumn 29, Issue 4, 1997, Pages 283-290

  Brace, Melanie ^a   McCauley, Elizabeth ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Mood; Oestrogen; Serotonin

Indexed keywords

ESTROGEN; NEUROTRANSMITTER; ORAL CONTRACEPTIVE AGENT;

AFFECTIVE NEUROSIS; AGING; CIRCADIAN RHYTHM; DEMENTIA; DEPRESSION; ESTROGEN BLOOD LEVEL; FEMALE; GROWTH; HORMONAL THERAPY; HUMAN; KINDLING; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTION; REVIEW; SEXUAL DEVELOPMENT; SIDE EFFECT; WELLBEING;

EID: 0030864395     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999349     Document Type: Review

References (24)

1. Buchanan CM, Eccles JS, Becker JB. Are adolescents victims of raging hormones: evidence for activational effects of hormones on moods and behavior at adolescence? Psychol Bull 1992; 111: 62-107.
2. Paikoff RL, Brooks-Gunn J, Warren M. Predictive effects of hormonal change on affective expression in adolescent females over the course of one year. J Youth Adolesc 1991; 20: 191-214.
3. Bancroft J. The premenstrual syndrome - a reappraisal of the concept and the evidence. Psychol Med 1993; Suppl 24: 1-47.
4. Pearistein T. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 1995; 173: 646-53.
5. Mortola J. Assessment and management of premenstrual syndrome. Curr Opin Obstet Gynecol 1992; 4: 877-85.
6. Warner P, Bancroft J, Dixson A, Hampson M. The relationship between perimenstrual depressive mood and depressive illness. J Affect Disord 1991; 23: 9-23.
7. Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom Med 1994; 56: 225-31.
8. Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 1986; 74: 576-86.
9. Rubinow DR, Schmidt PJ. The neuroendocrinology of menstrual cycle mood disorders. Ann NY Acad Sci 1995; 771: 648-59.
10. Rubinow DR, Hoban MC, Grover GN, et al. Premenstrual mood disorder and psychiatric illness. Am J Psychiatry 1985; 142: 1359-61.
11. Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su T. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987; 70: 533-7.
12. Watts JF, Butt WR, Logan-Edwards R, Holder G. Hormonal studies in women with premenstrual tension. Br J Obstet Gynaecol 1985; 92: 247-55.
13. Schmidt PJ, Purdy RH, Moore PH Jr, Paul SM, Rubinow DR. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 1994; 79: 1256-60.
14. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha-2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 1993; 34: 676-86.
15. Rapkin AJ. The role of serotonin in premenstrual syndrome. Clin Obstet Gynecol 1992; 35: 629-36.
16. Parry BL, Berga SL, Kripke DF, et al. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression. Arch Gen Psychiatry 1990; 47: 1139-46.
17. Freeman E, Rickels K, Sondheimer S. Fluvoxamine for premenstrual dysphoric disorder: a pilot study. J Clin Psychiatry 1996; 57: 56-60.
18. Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropharmacology 1995; 12: 167-76.
19. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55: 332-5.
20. Graham CA, Sherwin BB. A prospecive treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36: 257-66.
21. Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37: 195-202.
22. Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med 1990; 52: 86-96.
23. Halbreich U, Holtz I, Paul L. Premenstrual changes: impaired hormonal homeostasis. Endocrinol Metab Clin North Am 1988; 17: 173-94.
24. Parry BB. Reproductive factors affecting the course of affective illness in women. Womens Disord 1989; 12: 207-20.